Skip to main content

IVERIC DRC PH 3 MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF INTRAVITREAL ADMINISTRATION OF ZIMURA┬┐ (COMPLEMENT C5 INHIBITOR) IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

IVERIC bio, Inc.

Start Date

January 21, 2020

End Date

January 31, 2023
 

Administered By

Ophthalmology

Awarded By

IVERIC bio, Inc.

Start Date

January 21, 2020

End Date

January 31, 2023